Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1.

Nischang M, Sutmuller R, Gers-Huber G, Audigé A, Li D, Rochat MA, Baenziger S, Hofer U, Schlaepfer E, Regenass S, Amssoms K, Stoops B, Van Cauwenberge A, Boden D, Kraus G, Speck RF.

PLoS One. 2012;7(6):e38853. doi: 10.1371/journal.pone.0038853. Epub 2012 Jun 13.

2.

Fluorescent protein vectors for promoter analysis in lactic acid bacteria and Escherichia coli.

García-Cayuela T, de Cadiñanos LP, Mohedano ML, de Palencia PF, Boden D, Wells J, Peláez C, López P, Requena T.

Appl Microbiol Biotechnol. 2012 Oct;96(1):171-81. doi: 10.1007/s00253-012-4087-z. Epub 2012 Apr 27.

PMID:
22534822
3.

The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.

Markowitz M, Vaida F, Hare CB, Boden D, Mohri H, Hecht FM, Kalayjian RC, Conrad A, Mildvan D, Aberg J, Hogan C, Kilby JM, Balfour HH Jr, Schafer K, Richman D, Little S.

J Infect Dis. 2010 May 1;201(9):1298-302. doi: 10.1086/651664.

4.

Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection.

Mehandru S, Vcelar B, Wrin T, Stiegler G, Joos B, Mohri H, Boden D, Galovich J, Tenner-Racz K, Racz P, Carrington M, Petropoulos C, Katinger H, Markowitz M.

J Virol. 2007 Oct;81(20):11016-31. Epub 2007 Aug 8.

5.

Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaques.

Ho SH, Tasca S, Shek L, Li A, Gettie A, Blanchard J, Boden D, Cheng-Mayer C.

J Virol. 2007 Aug;81(16):8621-33. Epub 2007 May 30.

6.

Overcoming HIV-1 resistance to RNA interference.

Boden D, Pusch O, Ramratnam B.

Front Biosci. 2007 May 1;12:3104-16.

PMID:
17485285
7.

Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.

Mehandru S, Poles MA, Tenner-Racz K, Jean-Pierre P, Manuelli V, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M.

PLoS Med. 2006 Dec;3(12):e484. Erratum in: PLoS Med. 2006 Dec;3(12):e546.

8.

Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection.

Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M.

J Virol. 2007 Jan;81(2):599-612. Epub 2006 Oct 25.

9.

An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli.

Pusch O, Kalyanaraman R, Tucker LD, Wells JM, Ramratnam B, Boden D.

AIDS. 2006 Oct 3;20(15):1917-22.

PMID:
16988512
10.

Engineering mucosal RNA interference in vivo.

Zhang Y, Cristofaro P, Silbermann R, Pusch O, Boden D, Konkin T, Hovanesian V, Monfils PR, Resnick M, Moss SF, Ramratnam B.

Mol Ther. 2006 Sep;14(3):336-42. Epub 2006 Jun 12.

PMID:
16766229
11.

Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience.

Shet A, Berry L, Mohri H, Mehandru S, Chung C, Kim A, Jean-Pierre P, Hogan C, Simon V, Boden D, Markowitz M.

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):439-46.

PMID:
16652051
12.

Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin.

Pusch O, Boden D, Hannify S, Lee F, Tucker LD, Boyd MR, Wells JM, Ramratnam B.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):512-20.

PMID:
16284525
13.

Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.

Markowitz M, Mohri H, Mehandru S, Shet A, Berry L, Kalyanaraman R, Kim A, Chung C, Jean-Pierre P, Horowitz A, La Mar M, Wrin T, Parkin N, Poles M, Petropoulos C, Mullen M, Boden D, Ho DD.

Lancet. 2005 Mar 19-25;365(9464):1031-8.

PMID:
15781098
14.

HIV-1-specific RNA interference.

Boden D, Pusch O, Ramratnam B.

Curr Opin Mol Ther. 2004 Aug;6(4):373-80. Review.

PMID:
15468596
15.

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.

Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M.

J Exp Med. 2004 Sep 20;200(6):761-70. Epub 2004 Sep 13.

16.

Examination of gender bias in the evaluation and treatment of angina pectoris by cardiologists.

Blum M, Slade M, Boden D, Cabin H, Caulin-Glaser T.

Am J Cardiol. 2004 Mar 15;93(6):765-7.

PMID:
15019889
17.
18.

Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.

Boden D, Pusch O, Silbermann R, Lee F, Tucker L, Ramratnam B.

Nucleic Acids Res. 2004 Feb 13;32(3):1154-8. Print 2004.

19.

Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA.

Pusch O, Boden D, Silbermann R, Lee F, Tucker L, Ramratnam B.

Nucleic Acids Res. 2003 Nov 15;31(22):6444-9.

20.

Human immunodeficiency virus type 1 escape from RNA interference.

Boden D, Pusch O, Lee F, Tucker L, Ramratnam B.

J Virol. 2003 Nov;77(21):11531-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk